Science & Technology

DoW Lung Cancer Translational Research Award

Defense Health Agency Contracting Activity - DHACA

Opportunity #: HT942526LCRPTRA

Award Ceiling

N/A

Award Floor

N/A

Close Date

Sep 2, 2026

37 days left

Total Funding

$9.1M

Expected Awards

Posted Date

May 5, 2026

Cost Sharing Required

Grants.gov ID

362250

Description

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Translational Research Award (TRA) supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Research must address at least one of the FY26 LCRP areas of emphasis.Distinctive Features: This funding mechanism intends to support a broad range of translational studies and allows application submission under: Funding Level 1 Advanced/late-stage preclinical work or correlative studies; or Funding Level 2 Pilot clinical trials of novel interventions.

Apply on Grants.gov

Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.

View on Grants.gov

Disclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.